Literature DB >> 12072046

Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.

Gianluca Aimaretti1, Claudia Baffoni, Fabio Broglio, Joop A M Janssen, Ginevra Corneli, Romano Deghenghi, Aart Jan van der Lely, Ezio Ghigo, Emanuela Arvat.   

Abstract

OBJECTIVE: Ghrelin, a 28 amino acid acylated peptide, is a natural ligand of the GH secretagogues (GHS) receptor (GHS-R), which is specific for synthetic GHS. Similar to synthetic GHS, ghrelin strongly stimulates GH secretion but also displays significant stimulatory effects on lactotroph and corticotroph secretion. It has been hypothesized that isolated GH deficiency (GHD) could reflect hypothalamic impairment that would theoretically involve defect in ghrelin activity. PATIENTS: In the present study, we verified the effects of ghrelin (1 microg/kg i.v.) on GH, PRL, ACTH and cortisol levels in adult patients with isolated severe GHD [five males and one female, age (mean +/- SEM) 24.7 +/- 2.6 years, BMI 25.7 +/- 2.7 kg/m2]. In all patients, the GH response to insulin-induced hypoglycaemia (ITT, 0.1 IU regular insulin i.v.) and GH releasing hormone (GHRH) (1 microg/kg i.v.) + arginine (ARG, 0.5 g/kg i.v.) was also studied. The hormonal responses in GHD were compared with those in age-matched normal subjects (NS, seven males, age 28.6 +/- 2.9 years, BMI 22.1 +/- 0.8 kg/m2).
RESULTS: IGF-I levels in GHD were markedly lower than in NS (69.8 +/- 11.3 vs. 167.9 +/- 19.2 microg/l, P < 0.003). Ghrelin administration induced significant increase in GH, PRL, ACTH and cortisol levels in all GHD. In GHD, the GH response to ghrelin was higher (P < 0.05) than that to GHRH + ARG, which, in turn, was higher (P < 0.05) than that to ITT (9.2 +/- 4.1 vs. 5.3 +/- 1.7 vs. 1.4 +/- 0.4 microg/l). These GH (1 microg/l = 2 mU/l) responses in GHD were markedly lower (P < 0.0001) than those in NS (ghrelin vs. GHRH + ARG vs. ITT 92.1 +/- 16.7 vs. 65.3 +/- 8.9 vs. 17.7 +/- 3.5 microg/l). In GHD, the highest individual peak GH response to ghrelin was markedly lower than the lowest peak GH response in NS (28.5 vs. 42.9 microg/l). GHD and NS showed overlapping PRL (1 microg/l = 32 mU/l) (10.0 +/- 1.4 vs. 14.9 +/- 2.2 microg/l), ACTH (22.3 +/- 5.3 vs. 18.7 +/- 4.6 pmol/l) and cortisol responses (598.1 +/- 52.4 vs. 486.9 +/- 38.9 nmol/l).
CONCLUSIONS: This study shows that ghrelin is one of the most powerful provocative stimuli of GH secretion, even in those patients with isolated severe GHD. In this condition, however, the somatotroph response is markedly reduced while the lactotroph and corticotroph responsiveness to ghrelin is fully preserved, indicating that this endocrine activity is fully independent of mechanisms underlying the GH-releasing effect. These results do not support the hypothesis that ghrelin deficiency is a major cause of isolated GH deficiency but suggest that ghrelin might represent a reliable provocative test to evaluate the maximal GH secretory capacity provided that appropriate cut-off limits are assumed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072046     DOI: 10.1046/j.1365-2265.2002.01547.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system.

Authors:  L M Seoane; O Al-Massadi; F Barreiro; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

2.  Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus-pituitary disease.

Authors:  Valentina Gasco; Alessandro Berton; Mirko Parasiliti Caprino; Ioannis Karamouzis; Mauro Maccario; Ezio Ghigo; Silvia Grottoli
Journal:  Endocrine       Date:  2014-12-09       Impact factor: 3.633

Review 3.  Diagnosis of adult GH deficiency.

Authors:  V Gasco; G Corneli; S Rovere; C Croce; G Beccuti; A Mainolfi; S Grottoli; G Aimaretti; E Ghigo
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

4.  Diagnosing growth hormone deficiency in adults.

Authors:  Nigel Glynn; Amar Agha
Journal:  Int J Endocrinol       Date:  2012-07-26       Impact factor: 3.257

Review 5.  Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood.

Authors:  Ginevra Corneli; Valentina Gasco; Flavia Prodam; Silvia Grottoli; Gianluca Aimaretti; Ezio Ghigo
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

6.  Diagnostic value of a ghrelin test for the diagnosis of GH deficiency after subarachnoid hemorrhage.

Authors:  K Blijdorp; L Khajeh; G M Ribbers; E M Sneekes; M H Heijenbrok-Kal; H J G van den Berg-Emons; A J van der Lely; F van Kooten; S J C M M Neggers
Journal:  Eur J Endocrinol       Date:  2013-09-14       Impact factor: 6.664

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.